# Esco Lifesciences Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/esco-lifesciences-group

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Website: www.group.escolifesciences.com
- Total disclosed funding: $200M
- Latest round: Series A (Apr 1, 2021)
- Investors on record: 4

## About

Founded in 1978 and based in Singapore, Esco Lifesciences Group Ltd. provides support to health technology companies. In 2006, the firm started to expand its operations and launched its medical and pharma division until 2012. The firm has over 1,300 employees worldwide. In 2021, the firm has raised USD 200 million in Series A funding.

Esco Lifesciences Group Ltd. provides life sciences tools to health care industries. The firm also provides COVID-19 related equipment to fight against pandemics.

Esco Lifesciences Group Ltd. plans to use its Series A funding to create an innovation hub in Boston, focused on cell and gene therapy tools and technologies, increase research and development, and in-licensing efforts to develop and commercialize novel life science research tools in emerging domains.

## Funding rounds

- Series A, Apr 1, 2021, $200M — China Investment Corporation, Vivo Capital, SG Growth Capital, Novo Holdings

## Investors

- China Investment Corporation — Series A
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series A
- Novo Holdings — Series A